IN2015DN01018A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01018A IN2015DN01018A IN1018DEN2015A IN2015DN01018A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A IN 1018DEN2015 A IN1018DEN2015 A IN 1018DEN2015A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A
- Authority
- IN
- India
- Prior art keywords
- acetoxy
- propoxy
- diphenyl
- alkyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261681415P | 2012-08-09 | 2012-08-09 | |
| PCT/US2013/052626 WO2014025569A1 (fr) | 2012-08-09 | 2013-07-30 | Sels de pipéridinium quartenaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01018A true IN2015DN01018A (fr) | 2015-06-26 |
Family
ID=50068488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1018DEN2015 IN2015DN01018A (fr) | 2012-08-09 | 2013-07-30 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9896416B2 (fr) |
| EP (1) | EP2882711B1 (fr) |
| JP (1) | JP6345665B2 (fr) |
| KR (2) | KR20150040355A (fr) |
| CN (2) | CN108658842A (fr) |
| AU (1) | AU2013300009B2 (fr) |
| BR (1) | BR112015002832B1 (fr) |
| CA (1) | CA2881182C (fr) |
| EA (1) | EA029678B9 (fr) |
| HK (1) | HK1211572A1 (fr) |
| IL (1) | IL236996A0 (fr) |
| IN (1) | IN2015DN01018A (fr) |
| MX (1) | MX356386B (fr) |
| WO (1) | WO2014025569A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3265128A4 (fr) | 2015-03-06 | 2018-09-12 | Chase Pharmaceuticals Corporation | Combinaison d'agoniste des récepteurs muscariniques et d'oxybutynine dans un système thérapeutique transdermique |
| CA2992731A1 (fr) * | 2015-07-20 | 2017-01-26 | Chase Pharmaceuticals Corporation | Combinaison muscarinique d'un antagoniste selectif du recepteur m2 et d'un antagoniste non selectif peripherique pour le traitement de troubles hypocholinergiques |
| EP4354912A3 (fr) | 2019-08-22 | 2024-04-24 | Ofinno, LLC | Commande de politique pour accès multiples |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD106643A1 (fr) * | 1973-07-12 | 1974-06-20 | ||
| CN1285348A (zh) | 1999-08-20 | 2001-02-28 | 广东康美药业股份有限公司 | 盐酸丙哌维林合成工艺 |
| DE10129832A1 (de) | 2001-06-17 | 2003-07-10 | Berolina Drug Dev Ab Svedala | Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel |
| CA2384922C (fr) * | 2002-05-03 | 2008-09-02 | Purepharm Inc. | Produit topique de glycopyrrolate pour reduire la transpiration |
| KR100510788B1 (ko) | 2003-07-22 | 2005-08-26 | 동방에프티엘 주식회사 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
| KR100500760B1 (ko) | 2003-07-22 | 2005-07-14 | 동방에프티엘 주식회사 | 염산 프로피베린의 제조방법 |
| WO2005074918A1 (fr) * | 2004-02-06 | 2005-08-18 | Benzstrasse 1 D-61352 Bad Homburd | Combinaison d'anticholinergiques et de glucocorticoides pour le traitement prolonge de l'asthme et des broncho-pneumopathies chroniques obstructives |
| EP1921989A2 (fr) * | 2005-08-12 | 2008-05-21 | The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services | Mesure de l'avalanche neuronale |
| CN1951938A (zh) * | 2005-10-21 | 2007-04-25 | 刘丽娅 | 戊乙奎醚季铵盐及其衍生物 |
| SE0600876L (sv) | 2006-04-20 | 2007-10-21 | Sandvik Intellectual Property | Verktyg och skär för spånavskiljande bearbetning med primära och sekundära ingreppsmedel med rotationssymmetrisk form |
| CN101490003A (zh) * | 2006-04-24 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | 具有毒蕈碱m3受体拮抗剂活性、用于治疗入慢性支气管阻塞、哮喘和膀胱过动的新型环状氨基醇的取代烷基酯类化合物 |
| EP2013172A4 (fr) | 2006-04-24 | 2010-08-04 | Astrazeneca Ab | Nouveaux esters alkiliques d'amino-alcools cycliques avec activité antagoniste des récepteurs muscariniques m3, utiles par exemple, pour le traitement de l'obstruction bronchique chronique, de l'asthme et de l'hyperactivité de la vessie |
| EP2470504B1 (fr) * | 2010-03-15 | 2013-10-16 | Ramesha Andagar Ramakrishna | Synthèse de chlorhydrate de propivérine |
| KR101149821B1 (ko) | 2010-04-05 | 2012-05-24 | 하나제약 주식회사 | 디페닐아세테이트 유도체의 새로운 제조방법 |
| CN102218063B (zh) | 2011-04-12 | 2013-03-13 | 贵州神奇制药有限公司 | 盐酸丙哌维林药物的制备方法和产品及其检测方法 |
| IN2015DN01706A (fr) * | 2012-09-05 | 2015-05-22 | Chase Pharmaceuticals Corp |
-
2013
- 2013-07-30 BR BR112015002832-2A patent/BR112015002832B1/pt not_active IP Right Cessation
- 2013-07-30 MX MX2015001769A patent/MX356386B/es active IP Right Grant
- 2013-07-30 AU AU2013300009A patent/AU2013300009B2/en not_active Ceased
- 2013-07-30 EA EA201500209A patent/EA029678B9/ru unknown
- 2013-07-30 CN CN201810664740.3A patent/CN108658842A/zh active Pending
- 2013-07-30 JP JP2015526567A patent/JP6345665B2/ja active Active
- 2013-07-30 WO PCT/US2013/052626 patent/WO2014025569A1/fr active Application Filing
- 2013-07-30 US US14/419,381 patent/US9896416B2/en active Active
- 2013-07-30 CA CA2881182A patent/CA2881182C/fr active Active
- 2013-07-30 EP EP13827594.6A patent/EP2882711B1/fr active Active
- 2013-07-30 IN IN1018DEN2015 patent/IN2015DN01018A/en unknown
- 2013-07-30 KR KR20157006047A patent/KR20150040355A/ko not_active Application Discontinuation
- 2013-07-30 CN CN201380042085.3A patent/CN104603108A/zh active Pending
- 2013-07-30 KR KR1020207005139A patent/KR102240999B1/ko active IP Right Grant
-
2015
- 2015-01-29 IL IL236996A patent/IL236996A0/en unknown
- 2015-12-10 HK HK15112219.3A patent/HK1211572A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2882711B1 (fr) | 2017-10-25 |
| MX2015001769A (es) | 2015-05-08 |
| KR102240999B1 (ko) | 2021-04-15 |
| JP2015524469A (ja) | 2015-08-24 |
| CN108658842A (zh) | 2018-10-16 |
| CN104603108A (zh) | 2015-05-06 |
| AU2013300009B2 (en) | 2017-06-15 |
| KR20150040355A (ko) | 2015-04-14 |
| JP6345665B2 (ja) | 2018-06-20 |
| CA2881182C (fr) | 2021-01-26 |
| US9896416B2 (en) | 2018-02-20 |
| WO2014025569A1 (fr) | 2014-02-13 |
| AU2013300009A1 (en) | 2015-02-26 |
| EP2882711A1 (fr) | 2015-06-17 |
| EA029678B9 (ru) | 2018-07-31 |
| BR112015002832A2 (fr) | 2017-07-04 |
| EP2882711A4 (fr) | 2016-02-10 |
| HK1211572A1 (en) | 2016-05-27 |
| EA029678B1 (ru) | 2018-04-30 |
| BR112015002832B1 (pt) | 2022-08-16 |
| MX356386B (es) | 2018-05-28 |
| CA2881182A1 (fr) | 2014-02-13 |
| EA201500209A1 (ru) | 2015-05-29 |
| KR20200022522A (ko) | 2020-03-03 |
| US20150203452A1 (en) | 2015-07-23 |
| IL236996A0 (en) | 2015-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
| IL235767A (en) | Preserved pyrolidines, pharmaceuticals containing them and their uses | |
| PH12014502095A1 (en) | Estrogen receptor modulators and uses thereof | |
| MX2018003096A (es) | Composicion farmaceutica que contiene farmaco anionico, y metodo de preparacion para la misma. | |
| EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
| IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
| IN2015DN03984A (fr) | ||
| IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
| EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
| UY34730A (es) | Formulaciones farmacéuticas que comprenden antagonistas de ccr3 | |
| GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
| MX2016008369A (es) | Composicion farmaceutica que incluye palonosetron. | |
| MX2016001138A (es) | Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo. | |
| MY183914A (en) | Learning and memory improver | |
| PH12014502856A1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| IL246298A0 (en) | History of piperidine, their preparation and pharmaceutical preparations containing them | |
| MD20150053A2 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| IN2015DN01018A (fr) | ||
| IN2015DN02999A (fr) | ||
| MY183068A (en) | Pharmaceutical formulation comprising antibody | |
| WO2015022560A8 (fr) | Composition pharmaceutique stable contenant du bisoprolol et du ramipril | |
| WO2015044434A3 (fr) | Fluoro-9-méthyl-β-carboline | |
| WO2014115169A3 (fr) | Dispersion solide de crizotinib | |
| WO2017004172A8 (fr) | Synthèse totale de shishijimicine a et d'analogues de celle-ci |